Rock Springs Capital Management LP
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1595725
Baltimore, MD
Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,963,398
+$10,579,013 QoQ
Shares Held
453,156
-8.8% QoQ
Ownership
0.545%
of shares outstanding
% of Portfolio
2.54%
of 13F equity value
Holder Rank
#33
of 275 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rock Springs Capital Management LP holds $1,502,002,537 across 70 Biotechnology names. KYMR ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,105,210 | $206,983,728 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
2,179,069 | $123,792,909 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
174,999 | $93,965,713 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
798,145 | $93,438,835 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
692,598 | $76,899,155 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
This page
|
453,156 | $51,963,398 | |
| 7 | ARGX |
Argenx SE
|
52,750 | $48,939,867 | |
| 8 | ASND |
Ascendis Pharma A/S
|
168,750 | $45,009,000 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,963,398 | 453,156 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,384,385 | 496,871 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,661,532 | 496,871 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,491,168 | 450,374 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,654,321 | 450,374 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,743,740 | 794,437 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,603,331 | 1,034,137 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $49,667,439 | 1,049,386 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,744,594 | 1,163,973 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $61,193,967 | 1,522,238 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $38,756,179 | 1,522,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,910,478 | 1,504,351 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,198,797 | 1,487,551 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $36,396,869 | 1,228,379 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $30,645,363 | 1,227,779 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,787,595 | 1,046,743 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,277,057 | 775,879 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $31,988,630 | 755,875 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $47,113,706 | 742,065 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $43,052,131 | 732,927 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $30,386,559 | 626,527 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,162,254 | 621,777 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $44,259,630 | 713,865 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $22,938,969 | 709,965 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||